Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694

Sort by:

Severe Acute Respiratory Syndrome - Pipeline Review, H2 2019

US$ 2,000.00

Severe Acute Respiratory Syndrome - Pipeline Review, H2 2019 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Severe Acute Respiratory Syndrome (SARS) - Pi...

November 2019 54 pages

European Online Pharmacy (E-Pharma) Market: Insights, Trends & Forecast (2019-2023)

US$ 1,400.00

The European online pharmacy market is estimated to reach US$10.88 billion in 2023, growing at a CAGR of 4.20% for the period spanning from 2019 to 2023. The factors such as increasing aging populatio...

November 2019 76 pages

United States Vaccines Market Size, Share, Growth Opportunities, Future Trends, Top Key Players, and Forecast to 2026

US$ 2,190.00

The United States vaccines market is poised to reach a value of more than US$ 26 billion by 2026. “United States Vaccines Market Size, Share, Growth Opportunities, Future Trends, Top Key Players, and...

November 2019 150 pages

Global Conjugate Vaccines Market (2017 - 2022)

US$ 2,950.00

... order is placed. The market for conjugate vaccines is expected to increase, owing to global awareness about the benefits of vaccination for the prevention of ... diphtheria and tetanus toxoids and pertussis (DTP) conjugate vaccine occupied a share of 23% in 2017. The higher prevalence of respiratory diseases such ...

November 2019 90 pages

Global Brain Tumor Therapeutics Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025

US$ 3,449.00

The Global Brain Tumor Therapeutics Market is expected to grow from USD 2,136.54 Million in 2018 to USD 3,562.65 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 7.57%. The posit...

November 2019 112 pages

Global Breast Cancer Drugs Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025

US$ 3,449.00

The Global Breast Cancer Drugs Market is expected to grow from USD 14,231.65 Million in 2018 to USD 26,421.12 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 9.24%. The position...

November 2019 107 pages

Global Cervical Cancer Drugs Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025

US$ 3,449.00

The Global Cervical Cancer Drugs Market is expected to grow from USD 6,152.56 Million in 2018 to USD 8,456.35 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 4.64%. The position...

November 2019 118 pages

Global Electronic Drug Delivery System Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025

US$ 3,449.00

The Global Electronic Drug Delivery System Market is expected to grow from USD 7,234.45 Million in 2018 to USD 13,352.49 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 9.14%. T...

November 2019 119 pages

Global Kidney Cancer Drugs Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025

US$ 3,449.00

The Global Kidney Cancer Drugs Market is expected to grow from USD 4,521.65 Million in 2018 to USD 6,523.35 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 5.37%. The positionin...

November 2019 114 pages

Global Leukemia Therapeutics Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025

US$ 3,449.00

The Global Leukemia Therapeutics Market is expected to grow from USD 11,632.65 Million in 2018 to USD 17,952.64 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 6.39%. The positi...

November 2019 112 pages

Global Liver Cancer Drugs Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025

US$ 3,449.00

The Global Liver Cancer Drugs Market is expected to grow from USD 475.32 Million in 2018 to USD 1,131.65 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 13.19%. The positioning...

November 2019 105 pages

Global Lung Cancer Drugs Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025

US$ 3,449.00

The Global Lung Cancer Drugs Market is expected to grow from USD 16,823.65 Million in 2018 to USD 29,523.36 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 8.36%. The positionin...

November 2019 106 pages

Global Oncology Drugs Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025

US$ 3,449.00

The Global Oncology Drugs Market is expected to grow from USD 94,523.46 Million in 2018 to USD 154,235.36 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 7.24%. The positioning...

November 2019 116 pages

Global Ovarian Cancer Drugs Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025

US$ 3,449.00

The Global Ovarian Cancer Drugs Market is expected to grow from USD 2,193.41 Million in 2018 to USD 5,132.54 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 12.91%. The position...

November 2019 117 pages

Global Pancreatic Cancer Therapeutics Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025

US$ 3,449.00

The Global Pancreatic Cancer Therapeutics Market is expected to grow from USD 2,135.46 Million in 2018 to USD 4,003.63 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 9.39%. The...

November 2019 118 pages

Global Prostate Cancer Therapeutics Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025

US$ 3,449.00

The Global Prostate Cancer Therapeutics Market is expected to grow from USD 7,675.45 Million in 2018 to USD 11,321.51 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 5.70%. The...

November 2019 102 pages

Global Skin Cancer Diagnostics & Therapeutics Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025

US$ 3,449.00

The Global Skin Cancer Diagnostics & Therapeutics Market is expected to grow from USD 4,835.65 Million in 2018 to USD 9,215.68 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 9.6...

November 2019 119 pages

Global Tapentadol Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025

US$ 3,449.00

The Global Tapentadol Market is expected to grow from USD 2,956.45 Million in 2018 to USD 4,378.54 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 5.77%. The positioning of the...

November 2019 106 pages

Global Transdermal Drug Delivery System Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025

US$ 3,449.00

The Global Transdermal Drug Delivery System Market is expected to grow from USD 5,623.46 Million in 2018 to USD 7,989.45 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 5.14%. T...

November 2019 111 pages

Global Uterine Cancer Therapeutics & Diagnostics Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025

US$ 3,449.00

The Global Uterine Cancer Therapeutics & Diagnostics Market is expected to grow from USD 17,325.65 Million in 2018 to USD 25,521.12 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) o...

November 2019 100 pages

Indonesia and Philippines Vitamins and Nutraceuticals Market Outlook and Projections, 2019-2027

US$ 4,150.00

Functional beverages is slated to account for a share of 39.13% in 2018 in the Indonesia vitamins and nutraceuticals market. The growth of this segment can be attributed to the rising health concerns,...

November 2019 137 pages

Global Oral Anti-Diabetic Drugs Market: World Market Review and Analysis By Type, By Region, By Country (2019 Edition): Opportunities and Forecast (2019-2024)

US$ 2,400.00

EXECUTIVE SUMMARY The Oral anti diabetes drug was valued at USD 25.6 Billion in the year 2018. Over the recent years, oral anti-diabetes drug has been witnessing considerable growth on the back of r...

October 2019 275 pages

Pharmaceutical Continuous Manufacturing Market by Application (Generic Drug, Generic Medicine) and by Region, Trend, Forecast, Competitive Analysis, and Growth Opportunity 2019-2024

US$ 3,000.00

Continuous manufacturing processes produce drug ingredients or finished products such as tablets continuously, without having to wait for each batch to finish before beginning a new one. Advantages of...

October 2019 97 pages

Global Schizophrenia Drugs (Orals & Injectables) Market: Insights, Trends and Forecast (2019-2023)

US$ 1,600.00

The global schizophrenia market is estimated to reach US$10.43 billion in 2023, growing at a CAGR of 3.69%, for the period spanning from 2018 to 2023. The factors such as rising occurrence of schizoph...

October 2019 95 pages

Acinetobacter Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Acinetobacter Infections Drug pipeline report- 2020 is an annual R&D review of Acinetobacter Infections pipeline candidates. The report presents the current status of all major Acinetobacter Infection...

October 2019 150 pages

African Trypanosomiasis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

African Trypanosomiasis Drug pipeline report- 2020 is an annual R&D review of African Trypanosomiasis pipeline candidates. The report presents the current status of all major African Trypanosomiasis t...

October 2019 40 pages

Anthrax Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Anthrax Drug pipeline report- 2020 is an annual R&D review of Anthrax pipeline candidates. The report presents the current status of all major Anthrax therapeutic compounds. Detailed insights into Ant...

October 2019 70 pages

Aspergillosis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Aspergillosis Drug pipeline report- 2020 is an annual R&D review of Aspergillosis pipeline candidates. The report presents the current status of all major Aspergillosis therapeutic compounds. Detailed...

October 2019 80 pages

Bacillary Dysentery (Shigellosis) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Bacillary Dysentery (Shigellosis) Drug pipeline report- 2020 is an annual R&D review of Bacillary Dysentery (Shigellosis) pipeline candidates. The report presents the current status of all major Bacil...

October 2019 40 pages

Bacterial Vaginosis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Bacterial Vaginosis Drug pipeline report- 2020 is an annual R&D review of Bacterial Vaginosis pipeline candidates. The report presents the current status of all major Bacterial Vaginosis therapeutic c...

October 2019 50 pages

Botulism Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Botulism Drug pipeline report- 2020 is an annual R&D review of Botulism pipeline candidates. The report presents the current status of all major Botulism therapeutic compounds. Detailed insights into...

October 2019 40 pages

Burkholderia pseudomallei Infections (Melioidosis) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Burkholderia pseudomallei Infections (Melioidosis) Drug pipeline report- 2020 is an annual R&D review of Burkholderia pseudomallei Infections (Melioidosis) pipeline candidates. The report presents the...

October 2019 50 pages

Candidiasis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Candidiasis Drug pipeline report- 2020 is an annual R&D review of Candidiasis pipeline candidates. The report presents the current status of all major Candidiasis therapeutic compounds. Detailed insig...

October 2019 130 pages

Chagas Disease (American Trypanosomiasis) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Chagas Disease (American Trypanosomiasis) Drug pipeline report- 2020 is an annual R&D review of Chagas Disease (American Trypanosomiasis) pipeline candidates. The report presents the current status of...

October 2019 70 pages

Chikungunya Fever Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Chikungunya Fever Drug pipeline report- 2020 is an annual R&D review of Chikungunya Fever pipeline candidates. The report presents the current status of all major Chikungunya Fever therapeutic compoun...

October 2019 80 pages

Chlamydia Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Chlamydia Infections Drug pipeline report- 2020 is an annual R&D review of Chlamydia Infections pipeline candidates. The report presents the current status of all major Chlamydia Infections therapeuti...

October 2019 50 pages

Cholera Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Cholera Drug pipeline report- 2020 is an annual R&D review of Cholera pipeline candidates. The report presents the current status of all major Cholera therapeutic compounds. Detailed insights into Cho...

October 2019 50 pages

Coccidioidomycosis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Coccidioidomycosis Drug pipeline report- 2020 is an annual R&D review of Coccidioidomycosis pipeline candidates. The report presents the current status of all major Coccidioidomycosis therapeutic comp...

October 2019 40 pages

Community Acquired Pneumonia Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Community Acquired Pneumonia Drug pipeline report- 2020 is an annual R&D review of Community Acquired Pneumonia pipeline candidates. The report presents the current status of all major Community Acqui...

October 2019 70 pages

Cryptococcosis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Cryptococcosis Drug pipeline report- 2020 is an annual R&D review of Cryptococcosis pipeline candidates. The report presents the current status of all major Cryptococcosis therapeutic compounds. Detai...

October 2019 40 pages

Cryptosporidiosis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Cryptosporidiosis Drug pipeline report- 2020 is an annual R&D review of Cryptosporidiosis pipeline candidates. The report presents the current status of all major Cryptosporidiosis therapeutic compoun...

October 2019 40 pages

Dengue Fever Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Dengue Fever Drug pipeline report- 2020 is an annual R&D review of Dengue Fever pipeline candidates. The report presents the current status of all major Dengue Fever therapeutic compounds. Detailed in...

October 2019 150 pages

Diphtheria Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Diphtheria Drug pipeline report- 2020 is an annual R&D review of Diphtheria pipeline candidates. The report presents the current status of all major Diphtheria therapeutic compounds. Detailed insights...

October 2019 70 pages

Epstein–Barr Virus (HHV-4) Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Epstein–Barr Virus (HHV-4) Infections Drug pipeline report- 2020 is an annual R&D review of Epstein–Barr Virus (HHV-4) Infections pipeline candidates. The report presents the current status of all maj...

October 2019 90 pages

Genital Herpes Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Genital Herpes Drug pipeline report- 2020 is an annual R&D review of Genital Herpes pipeline candidates. The report presents the current status of all major Genital Herpes therapeutic compounds. Detai...

October 2019 70 pages

Gonorrhea Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Gonorrhea Drug pipeline report- 2020 is an annual R&D review of Gonorrhea pipeline candidates. The report presents the current status of all major Gonorrhea therapeutic compounds. Detailed insights in...

October 2019 50 pages

Haemophilus influenzae Type B Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Haemophilus influenzae Type B Infections Drug pipeline report- 2020 is an annual R&D review of Haemophilus influenzae Type B Infections pipeline candidates. The report presents the current status of a...

October 2019 60 pages

Hand, Foot and Mouth Disease Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Hand, Foot and Mouth Disease Drug pipeline report- 2020 is an annual R&D review of Hand, Foot and Mouth Disease pipeline candidates. The report presents the current status of all major Hand, Foot and...

October 2019 40 pages

Hepatitis A Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Hepatitis A Drug pipeline report- 2020 is an annual R&D review of Hepatitis A pipeline candidates. The report presents the current status of all major Hepatitis A therapeutic compounds. Detailed insig...

October 2019 30 pages

Hepatitis D Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Hepatitis D Drug pipeline report- 2020 is an annual R&D review of Hepatitis D pipeline candidates. The report presents the current status of all major Hepatitis D therapeutic compounds. Detailed insig...

October 2019 50 pages

Filters

Clear all

Price

—

Date

—

Pages

—

Offers

Discount Offer from GMD Research

Special Offer from MP Advisors

Special Offer on Therapy Class R...